10-Q Filing

HEALTHTECH SOLUTIONS, INC./UT CIK: 1307624 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001262463-22-000087`
Period End Date	20220331
Filing Date	20220520
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	hltt10q3312022_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 36 Cash Flow Statement 40 Stockholders Equity 11

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.11K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$99.69K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$138.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$431.32K	USD	Point-in-time
Loan receivable	`LoansReceivableHeldForSaleAmount`	-	USD	Point-in-time
Loan receivable	`LoansReceivableHeldForSaleAmount`	$168.00K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$313.10K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$531.01K	USD	Point-in-time
Investment in and advance to non-consolidated affiliate	`DueFromAffiliateNoncurrent`	$110.00K	USD	Point-in-time
Investment in and advance to non-consolidated affiliate	`DueFromAffiliateNoncurrent`	$110.00K	USD	Point-in-time
Fixed Assets acquired net of accumulated depreciation	`EnergyMarketingContractsAssetsCurrent`	$113.33K	USD	Point-in-time
Fixed Assets acquired net of accumulated depreciation	`EnergyMarketingContractsAssetsCurrent`	-	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$129.80K	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Long Term Assets	`TotalLongTermAssets`	$353.13K	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Long Term Assets	`TotalLongTermAssets`	$110.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total Assets	`Assets`	$423.10K	USD	Point-in-time
Total Assets	`Assets`	$884.14K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	66.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$988.45K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$733.74K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	66.97M	shares	Point-in-time
Loans from non-affiliated parties	`DueToRelatedPartiesCurrent`	$507.50K	USD	Point-in-time
Loans from shareholders	`LoansFromShareholders`	$336.92K	USD	Point-in-time
Loans from shareholders	`LoansFromShareholders`	$837.10K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.07M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.33M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.33M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.07M	USD	Point-in-time
Series A preferred stock, $0.001 par value, 2,000,000 authorized, 110,520 and 156,837 issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$110.00	USD	Point-in-time
Series A preferred stock, $0.001 par value, 2,000,000 authorized, 110,520 and 156,837 issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$110.00	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 66,965,933 and 9,701,269 issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$66.97K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 66,965,933 and 9,701,269 issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$66.97K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.83M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.22M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.55M	USD	Point-in-time
Stockholders' Equity (Deficit) Attributable to the Company:	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Stockholders' Equity (Deficit) Attributable to the Company:	`StockholdersEquity`	$-647.56K	USD	Point-in-time
Non controlling Interest	`MinorityInterest`	-	USD	Point-in-time
Non controlling Interest	`MinorityInterest`	$-125.97K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.45M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-851.91K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-647.56K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$423.10K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$884.14K	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$119.82K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$338.63K	USD	1 Quarter
General and administrative-related party	`OtherGeneralAndAdministrativeExpense`	$45.00K	USD	1 Quarter
General and administrative-related party	`OtherGeneralAndAdministrativeExpense`	$30.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$84.95K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$385.42K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$18.00K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$18.00K	USD	1 Quarter
Depreciation & Amortization	`AdjustmentForAmortization`	$9.72K	USD	1 Quarter
Depreciation & Amortization	`AdjustmentForAmortization`	$14.30K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$262.49K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$801.35K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-801.35K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-262.49K	USD	1 Quarter
Interest expense	`InterestExpense`	$38.60K	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$7.21K	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
Total Other Expenses	`OtherExpenses`	-	USD	1 Quarter
Total Other Expenses	`OtherExpenses`	$31.39K	USD	1 Quarter
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-801.35K	USD	1 Quarter
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-293.88K	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net Loss	`ProfitLoss`	$801.35K	USD	1 Quarter
Net Loss	`ProfitLoss`	$293.88K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetLossAttributableToNoncontrollingInterest`	$125.97K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net Loss attributable to Controlling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-675.38K	USD	1 Quarter
Net Loss attributable to Controlling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-293.88K	USD	1 Quarter
Basic and diluted	`BasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted	`BasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted`	66.97M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted`	9.70M	shares	1 Quarter

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAllocatedToGeneralPartners`	$-801.35K	USD	1 Quarter
Net loss	`NetIncomeLossAllocatedToGeneralPartners`	$293.88K	USD	1 Quarter
Amortization expense	`AmortizationOfAcquisitionCosts`	$9.72K	USD	1 Quarter
Amortization expense	`AmortizationOfAcquisitionCosts`	$7.63K	USD	1 Quarter
Depreciation expense	`DepreciationAndAmortization`	$6.67K	USD	1 Quarter
Amortization of discount on convertible debenture	`AmortizationOfDebtDiscountPremium`	$27.30K	USD	1 Quarter
Fair value change in derivative liabilities	`UnrealizedGainLossOnDerivatives`	$7.21K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-10.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$33.32K	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$11.30K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-80.17K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$104.36K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$96.56K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$150.35K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-565.65K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-226.38K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds of loans from shareholders	`ProceedsOfLoansFromShareholders`	$49.12K	USD	1 Quarter
Proceeds of loans from shareholders	`ProceedsOfLoansFromShareholders`	$500.18K	USD	1 Quarter
Loan receivable	`PaymentsToAcquireLoansReceivable`	$349.43K	USD	1 Quarter
Loans from non-affiliated parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$507.50K	USD	1 Quarter
Capital contributions	`ProceedsFromContributionsFromParent`	$50.00K	USD	1 Quarter
Paid In Capital	`PaidInCapital`	$-4.56K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$103.68K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$658.25K	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$92.59K	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-122.70K	USD	1 Quarter
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$99.69K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.29K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.11K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$99.69K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.29K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.11K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	1 Quarter

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance at December 31, 2021	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Balance at December 31, 2021	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.45M	USD	Point-in-time
Balance at December 31, 2021	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-851.91K	USD	Point-in-time
Balance at December 31, 2021	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-647.56K	USD	Point-in-time
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$4.56K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-293.88K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-801.35K	USD	1 Quarter
Balance at March 31, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Balance at March 31, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.45M	USD	Point-in-time
Balance at March 31, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-851.91K	USD	Point-in-time
Balance at March 31, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-647.56K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.